FDA label
What is maraviroc used for?
The FDA-approved uses of maraviroc, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Maraviroc tablets are indicated in combination with other antiretroviral agents for the treatment of only CCR5-tropic human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients 2 years of age and older weighing at least 10 kg.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted maraviroc?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Maraviroc, tablet, film coated
Indications and Usage, quoted from the label by Rhodes Pharmaceuticals LLC (ANDA216143). Cross-references to other label sections are left out.
Maraviroc tablets are indicated in combination with other antiretroviral agents for the treatment of only CCR5-tropic human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients 2 years of age and older weighing at least 10 kg.
Limitations of Use:
- Maraviroc tablets are not recommended in patients with dual/mixed- or CXCR4-tropic HIV-1.
Source: DailyMed label, set id c35f72dc-d90e-43f8-9899-f7d1da89460d, version 5, effective September 30, 2026. NDC 42858-246, one of 16 listings for this product.
Questions
What is maraviroc used for?
The FDA label says: “Maraviroc tablets are indicated in combination with other antiretroviral agents for the treatment of only CCR5-tropic human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients 2 years of age and older weighing at least 10 kg.”
What drug class is maraviroc?
FDA lists maraviroc in the CCR5 Co-receptor Antagonist established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.